Financials Shanghai Kai Kai Industry Company Limited

Equities

600272

CNE000001766

Pharmaceuticals

End-of-day quote Shanghai S.E. 06:00:00 2024-05-14 pm EDT 5-day change 1st Jan Change
10.3 CNY -1.62% Intraday chart for Shanghai Kai Kai Industry Company Limited -3.38% -9.17%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,546 1,513 1,398 1,588 1,883 2,097
Enterprise Value (EV) 1 1,380 1,230 1,047 1,407 1,622 1,857
P/E ratio 50.7 x 84.6 x 118 x 91.2 x 59.9 x 70.9 x
Yield 0.63% 0.37% 0.24% 0.33% 0.52% 0.43%
Capitalization / Revenue 1.76 x 1.74 x 1.83 x 2.37 x 2.11 x 2.27 x
EV / Revenue 1.57 x 1.41 x 1.37 x 2.1 x 1.81 x 2.01 x
EV / EBITDA 41.6 x 42.6 x 21.8 x 60.3 x 58.6 x 56.6 x
EV / FCF 69.2 x 62.1 x 12.6 x -6.72 x 26.5 x -58.5 x
FCF Yield 1.45% 1.61% 7.91% -14.9% 3.78% -1.71%
Price to Book 3.48 x 3.59 x 3.34 x 3.73 x 4.09 x 4.62 x
Nbr of stocks (in thousands) 243,000 243,000 243,000 243,000 243,000 243,000
Reference price 2 7.100 7.610 7.100 8.210 9.580 11.34
Announcement Date 3/28/19 3/27/20 3/25/21 1/27/22 3/29/23 3/29/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 877.6 870.4 761.8 669.8 894.2 925.1
EBITDA 1 33.17 28.88 48.09 23.33 27.67 32.81
EBIT 1 19.52 13.88 32.76 7.844 8.211 13.53
Operating Margin 2.22% 1.59% 4.3% 1.17% 0.92% 1.46%
Earnings before Tax (EBT) 1 46.51 32.98 22.83 24.63 60.74 54.93
Net income 1 35.23 21.98 13.67 21.72 39.95 39.3
Net margin 4.01% 2.52% 1.8% 3.24% 4.47% 4.25%
EPS 2 0.1400 0.0900 0.0600 0.0900 0.1600 0.1600
Free Cash Flow 1 19.94 19.8 82.8 -209.5 61.24 -31.77
FCF margin 2.27% 2.27% 10.87% -31.28% 6.85% -3.43%
FCF Conversion (EBITDA) 60.12% 68.57% 172.18% - 221.3% -
FCF Conversion (Net income) 56.59% 90.1% 605.51% - 153.28% -
Dividend per Share 2 0.0450 0.0280 0.0170 0.0270 0.0500 0.0490
Announcement Date 3/28/19 3/27/20 3/25/21 1/27/22 3/29/23 3/29/24
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 167 283 350 180 261 240
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 19.9 19.8 82.8 -210 61.2 -31.8
ROE (net income / shareholders' equity) 7.01% 4.25% 2.48% 3.07% 7.13% 6.92%
ROA (Net income/ Total Assets) 1.18% 0.84% 1.96% 0.47% 0.45% 0.67%
Assets 1 2,974 2,607 696 4,666 8,836 5,897
Book Value Per Share 2 2.040 2.120 2.120 2.200 2.340 2.450
Cash Flow per Share 2 0.6700 0.9500 1.100 0.7100 1.240 0.6500
Capex 1 1.68 4.55 6.86 240 3.89 7.27
Capex / Sales 0.19% 0.52% 0.9% 35.88% 0.44% 0.79%
Announcement Date 3/28/19 3/27/20 3/25/21 1/27/22 3/29/23 3/29/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 600272 Stock
  4. Financials Shanghai Kai Kai Industry Company Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW